tofacitinib / Towa Pharma - LARVOL DELTA

Stephen B. Hanauer, MD, on Improvements in Targeted IBD Therapies (Autoimmune Learning Network - HMP) - "Dr Hanauer discusses his presentation from the Interdisciplinary Autoimmune Summit on the advances and improvements made - and coming in the future -in targeted biologic and small molecule therapeutics for the management of inflammatory bowel disease."

Video

Frequently Asked Questions JAK Inhibitors in RA (Clinical Care Options) - "Released: December 10, 2020; Currently, 3 JAK inhibitors are approved by the FDA for treatment of RA: baricitinib, upadacitinib, and tofacitinib. Initially, patients can be monitored as you would with methotrexate by checking their complete blood count and complete metabolic panel more frequently for up to a month after they start the drug."

Interview

Drug approval reports (FDA) - Tofacitinib ANDA tentative approval for Breckenridge Pharms approved on 7th Jun, 2019.

ANDA